A Preliminary Study on the Key Factors of Biopharmaceutical CDMO Ecosystem Development and Digital Resilience Building

The aim of the research is to identify the main factors for developing the biopharmaceutical CDMO ecosystem. In addition, the evaluation criteria for biotech CDMOs building digital resilience are also analyzed. The data collection and analysis of this study are divided into two stages. First, the study employed semi-structured, in-depth interviews to collect valuable insights from key industrial KOLs. Then the expert questionnaires were distributed to conduct a survey of experts in Taiwan’s biopharmaceutical related industries. The main targets include a total of 60 experts from CDMO manufacturers, process equipment and solution suppliers, and MAH manufacturers. The conclusion indicates that the strategic development factors for biotechnology latecomers to catch up via regulatory and smart manufacturing paths.